Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul K Flanagan

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Gastroenterology Research|October 1, 2012
Corticosteroids in the Treatment of Pseudomembranous Colitis: A Report of 3 CasesElla Sykes, Patrick McDonald, Paul K Flanagan
World Journal of Gastroenterology|August 2, 2014
Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel diseaseAhmed Tawfik, Paul K Flanagan, Barry J Campbell
Digestive Diseases (Basel, Switzerland)|July 17, 2012
Lessons from diversion studies and antibacterial interventionsPaul K Flanagan, Barry J Campbell, Jonathan M Rhodes
Gut|November 27, 2013
A rare cause of weight lossPaul K Flanagan, Sarah E Coupland, Arvind Arumainathan, et al.
Inflammatory Bowel Diseases|April 4, 2015
Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin DPaul K Flanagan, Direkrit Chiewchengchol, Helen L Wright, et al.
Digestive Diseases and Sciences|November 27, 2022
Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease PatientsGerum Gashaw Gebeyehu, Joseph Fiske, Eleanor Liu, et al.
Inflammatory Bowel Diseases|August 3, 2024
Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease PatientsGerum Gashaw Gebeyehu, Giacomo Broglio, Eleanor Liu, et al.
Digestive Diseases and Sciences|July 19, 2020
Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's DiseaseJonathan M Rhodes, Sreedhar Subramanian, Paul K Flanagan, et al.
Gut|July 13, 2013
Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancerMaelle Prorok-Hamon, Melissa K Friswell, Abdullah Alswied, et al.
European Journal of Gastroenterology & Hepatology|September 28, 2022
Safety and effectiveness of ustekinumab in elderly Crohn's disease patientsJoseph Fiske, Eleanor Liu, Jimmy K Limdi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Gastroenterology Research|October 1, 2012
Corticosteroids in the Treatment of Pseudomembranous Colitis: A Report of 3 CasesElla Sykes, Patrick McDonald, Paul K Flanagan
World Journal of Gastroenterology|August 2, 2014
Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel diseaseAhmed Tawfik, Paul K Flanagan, Barry J Campbell
Digestive Diseases (Basel, Switzerland)|July 17, 2012
Lessons from diversion studies and antibacterial interventionsPaul K Flanagan, Barry J Campbell, Jonathan M Rhodes
Gut|November 27, 2013
A rare cause of weight lossPaul K Flanagan, Sarah E Coupland, Arvind Arumainathan, et al.
Inflammatory Bowel Diseases|April 4, 2015
Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin DPaul K Flanagan, Direkrit Chiewchengchol, Helen L Wright, et al.
Digestive Diseases and Sciences|November 27, 2022
Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease PatientsGerum Gashaw Gebeyehu, Joseph Fiske, Eleanor Liu, et al.
Inflammatory Bowel Diseases|August 3, 2024
Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease PatientsGerum Gashaw Gebeyehu, Giacomo Broglio, Eleanor Liu, et al.
Digestive Diseases and Sciences|July 19, 2020
Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's DiseaseJonathan M Rhodes, Sreedhar Subramanian, Paul K Flanagan, et al.
Gut|July 13, 2013
Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancerMaelle Prorok-Hamon, Melissa K Friswell, Abdullah Alswied, et al.
European Journal of Gastroenterology & Hepatology|September 28, 2022
Safety and effectiveness of ustekinumab in elderly Crohn's disease patientsJoseph Fiske, Eleanor Liu, Jimmy K Limdi, et al.
Pageof 2